Stem Cell Revolution

In this episode of Stem Cell Revolution, Donna Chang and Jan Shultis dive into the science of aging and longevity. They explore the critical difference between lifespan and healthspan—not just living longer, but living better with greater mobility, independence, and vitality.The discussion covers key biological processes behind aging, including chronic inflammation, cellular senescence or “zombie cells,” and the body’s declining regenerative capacity. They examine how mesenchymal stem cells may help by modulating the immune system, reducing inflammation, and restoring the body’s natural ability to repair itself.Highlights include recent research on stem cell therapy for frailty, the potential for preventative approaches, and why cultured autologous stem cells from your own body can remain highly functional regardless of age. The episode emphasizes scientifically grounded hope for regenerative medicine in addressing age-related decline.Learn what experts are discovering about maintaining vibrant health well into later decades and the future role of cellular therapies in longevity science.Learn MoreWebsite: https://www.hope.bio/X (Twitter): @hopebiosciencesInstagram: @hope.bioFacebook: https://www.facebook.com/share/1Qk9jgqq8W/?mibextid=wwXIfrLinkedIn: https://www.linkedin.com/company/hopebio/YouTube Channel: https://www.youtube.com/@hopebiosciences#StemCells #Longevity #Healthspan #RegenerativeMedicine #StemCellResearch #CellularTherapy #AgingScience #VibrantAging

Stem cell banking is a multi-billion dollar industry—but what are families actually storing when they bank stem cells?In this episode of Stem Cell Revolution, we break down what adult stem cell banking is and the objectives for storage. We explain what stem cell banks actually store, how different types of stem cells are collected, and what the realistic potential of these cells is in medicine today.We also explain how adult stem cell banking works at Hope Biosciences and how it differs from many traditional stem cell storage models.Stem cells hold enormous promise for the future of medicine—but understanding the science behind how they are collected, processed, and stored is critical for making informed decisions.If you've ever thought about banking your stem cells, this episode is a must-watch!Subscribe for more stories of hope and healing in regenerative medicine! What's your biggest takeaway from this episode? Comment below!Learn More:Website: https://www.hope.bioX (Twitter): @hopebio_orgInstagram: @hopebio_orgFacebook: https://www.facebook.com/HopeBiosciencesResearchFoundationLinkedIn: https://www.linkedin.com/company/hope-biosciences-research-foundationYouTube Channel: https://www.youtube.com/@HopeBiosciencesResearchFoundation#StemCellBanking #RegenerativeMedicine #MesenchymalStemCells #AdultStemCells #HopeBiosciences #StemCellTherapy #MSCs #CellBanking #CultureExpandedCells #StemCellEducation #FutureTherapies #CellularHealth

Why Are Stem Cells So Expensive? The Real Cost Breakdown in 2026In this episode of Stem Cell Revolution, Donna Chang and Jan Shultis tackle one of the most common and uncomfortable questions in regenerative medicine:Why do stem cell treatments cost so much?From $5,000 cash-pay clinic procedures… to $25,000 overseas medical tourism visits… to FDA-approved cellular therapies costing $200,000 to $400,000 — we break down exactly what you’re paying for and why.This isn’t just a conversation about price tags. It’s about transparency, access, safety, and the future of affordable regenerative medicine.In this episode, we cover:• The difference between same-day procedures and true manufactured cell products• Why many “stem cell” products in the U.S. contain no viable stem cells• The hidden costs behind overseas treatments and medical tourism• Why FDA-approved therapies cost hundreds of thousands of dollars• The real reason hospital-based cellular therapies are so expensive• How research, testing, and regulatory safeguards impact pricing• The economics of chronic disease vs regenerative therapyWe also discuss real examples, including:• Hematopoietic stem cell transplants and why they can cost $400,000• FDA-approved orthopedic and pediatric cellular therapies• The recent Mesoblast approval for acute GvHD• The long-term financial burden of diseases like Parkinson’s, MS, and rheumatoid arthritisThen we turn to the bigger question:Is there a way to make stem cell therapy both safe AND affordable?Donna shares how Hope Biosciences approached the problem differently by focusing first on safety, speed, and standardization to dramatically reduce manufacturing costs without sacrificing quality.We break down what a monthly regenerative treatment model could look like compared to current biologic drug costs of $60,000 to $100,000 per year.If you’ve ever wondered:• Why aren’t stem cells covered by insurance?• Why do some treatments cost $5,000 and others $200,000?• Is overseas treatment worth the risk?• Can regenerative medicine ever be truly accessible?This episode is essential listening.The future of stem cell therapy isn’t just about science. It’s about affordability, scalability, and real-world access.We’d love to hear your thoughts. Drop your questions in the comments and let us know what topics you want us to cover next.#StemCellRevolution #RegenerativeMedicine #StemCells #CellTherapy #HealthcareCosts #FDA #Biologics #MedicalInnovation #HopeBiosciences

As we kick off the new year, it’s time for a reset.In this episode of Stem Cell Revolution, we reflect on the resolutions regenerative medicine must commit to — not just for the next 12 months, but for the future of the field. From patients and providers to industry, government, and the deeper meaning of hope, this conversation centers on accountability, scientific rigor, and trust.Regenerative medicine holds extraordinary promise but progress depends on the choices we make and the processes we change. Hope without evidence erodes trust. Evidence without compassion misses the point. The future of stem cells depends on holding both at the same time.This episode is an invitation to pause, recalibrate, and move forward collectively and quickly!Subscribe for more updates on the latest in stem cell science and hit the bell 🔔 to never miss an episode!Follow us!WEBSITE - https://www.hope.bioINSTAGRAM - / hope.bio TWITTER - / hopebiosciences FACEBOOK - / hopebiosciences#StemCellResolutions #StemCellRevolution #RegenerativeMedicine #ClinicalResearch #CellTherapy #MSCs #ScienceNotHype #PatientFirst #MedicalInnovation

Join us for our exclusive year-end recap as we celebrate the incredible progress in stem cell therapy throughout 2025! 🚀In this episode, we break down:The Top 3 game-changing moments that defined the yearThe latest clinical program updatesThe inspiring data and statistics showing our progress this year.Whether you're a patient, researcher, or simply passionate about the future of medicine, this episode is packed with insights, optimism, and evidence that the stem cell revolution is accelerating.Don't miss it – watch now and see why 2025 was a pivotal year for regenerative medicine! 💉🧬#StemCellRevolution #StemCellTherapy #RegenerativeMedicine #2025AnnualReport #ClinicalTrials #HopeInTheNumbers #StemCellBreakthroughsSubscribe for more updates on the latest in stem cell science and hit the bell 🔔 to never miss an episode!Follow us!WEBSITE - https://www.hope.bioINSTAGRAM - / hope.bio TWITTER - / hopebiosciences FACEBOOK - / hopebiosciences

This Thanksgiving, Stem Cell Revolution sits down with a true Houston legend: Jim “Mattress Mack” McIngvale. Known nationwide for his high-energy furniture commercials and record-breaking sports bets, Mack is so much more than a marketing icon. Here in Houston, he’s a community pillar—opening his stores during hurricanes, delivering mattresses to veterans, supporting families in need, and showing up every time his city calls.In this powerful conversation, Mack shares what truly drives him: grit, gratitude, faith, and an unwavering commitment to serving others. We explore the moments that shaped him, the values that keep him grounded, and how he keeps himself strong, healthy and energized for the work still to come. This episode is a celebration of resilience, service, and the heart of Thanksgiving.If you’ve ever wondered why Mattress Mack shows up the way he does, this is the story.Expecting family this Thanksgiving? Give them a warm welcome with a comfy MacZcliner and new mattress! Buy today and  ⁨@galleryfurniture⁩  delivers tonight!! (Stem cells not included)👇 Share your comments!🔔 Subscribe for more episodes of the Stem Cell Revolution.📍 Produced by Hope BiosciencesLinks:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences

Is cord blood banking the biggest stem cell scam of all time? We dive deep into the science to answer this question once and for all. Episode Resources: July 15, 2024 New York Times article " “Promised Cures, Tainted Cells: How Cord Blood Banks Mislead Parents” by investigative reporter Sarah Kliff and Azeen Ghorayshi https://www.nytimes.com/2024/07/15/health/cord-blood-storage-contamination.htmlResponse to the article by the Cord Blood Association: https://www.cb-association.org/assets/docs/CBA%20Letter%20to%20the%20Editor%20of%20the%20New%20York%20Times_7.16.24.pdfParent's Guide to Cord Blood - Odds of Using Cord Bloodhttps://parentsguidecordblood.org/en/oddsAmerican College of Obstetricians & Gynecologists (ACOG) Opinionhttps://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/03/umbilical-cord-blood-bankingAmerican Academy of Pediatrics (AAP) Policy Statement https://publications.aap.org/pediatrics/article/140/5/e20172695/37866/Cord-Blood-Banking-for-Potential-Future?autologincheck=redirectedWorld Marrow Donor Association (WMDA) Policy Statementhttps://bloodstemcell.hrsa.gov/sites/default/files/bloodstemcell/donor-information/word-marrow-donor-association.pdfThe European Group on Ethics in Science and New Technologies (EGE) Opinionhttps://ec.europa.eu/commission/presscorner/detail/en/ip_04_364Have questions about what we do? Learn about the hope banking process and put us to the test! Watch now on YouTube!https://youtu.be/man4k1uUmeA?si=99tvV-0pQsk-AzC9https://youtu.be/0lnvlEAmrtg?si=l_cXROe1-H_eB0Do💡 Have questions? Leave them in the comments—we read every one!👍 Don’t forget to like, subscribe, and share to help more families make informed choices.#CordBlood #StemCells #CellTherapy #PublicDonation #PrivateBanking #ParentingScience #MedicalResearch

If stem cells are so great, why don’t you hear more about them? In this episode of Stem Cell Revolution, hosts Donna Chang and Jan Shultis dive into the hidden barriers that keep groundbreaking science out of the spotlight. From the medical establishment to the world of peer reviewed literature, Donna and Jan pull back the curtain on the censorship challenges facing regenerative medicine today.What you’ll learn in this episode:- Why your doctor may not be equipped to answer your questions about stem cells- How the peer review process affects access to information- Digital barriers making it so hard to find accurate information💡 If you’ve ever wondered why you’ve never heard about certain breakthroughs, this episode is a must-watch.Read our RA Study Paper: https://pmc.ncbi.nlm.nih.gov/articles/PMC8896321/Pumpkin Pie Crochet Coaster Drawing! In celebration of Giving Tuesday, every donation given here https://www.hopebio.org/donate will be automatically entered to win. Donations made from 09/12/2025 to 12/2/2025 will be eligible. Every dollar donated to the Hope Biosciences Research Foundation supports stem cell research in the form of human clinical trials. These trials make a direct impact to the lives of those suffering from incurable conditions. Thank you for your support!👉 Don’t forget to like, comment!🔔 Subscribe for more episodes of the Stem Cell Revolution.📍 Produced by Hope BiosciencesLinks:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences#StemCells #Censorship #RegenerativeMedicine #HopeBiosciences #StemCellRevolution

Florida just passed a groundbreaking new law allowing physicians to administer non-FDA-approved stem cell therapies—but what does it really mean for patients, providers, and the future of regenerative medicine?In this episode of Stem Cell Revolution, we break down Florida’s controversial stem cell legislation:✅ What treatments are allowed✅ Who can administer them✅ What safeguards are in place (and what’s missing)✅ How it compares to Texas’ stem cell law✅ What this means for patients, clinicians and manufacturers Whether you’re a clinician, patient, or just curious about the future of medicine—don’t miss this deep dive into state-level stem cell reform.👇 Drop your thoughts in the comments and ask us questions! 🔔 Subscribe for more episodes of the Stem Cell Revolution.📍 Produced by Hope BiosciencesLinks:WEBSITE - https://www.hope.bioINSTAGRAM - instagram_1x.png / hope.bio TWITTER - twitter_1x_v2.png / hopebiosciences FACEBOOK - facebook_1x.png / hopebiosciences #StemCellRevolution #StemCellTherapy #FloridaLaw #RegenerativeMedicine #FDA #RightToTry #StemCells #HealthPolicy

Is the FDA finally loosening its grip on regenerative medicine?In this landmark episode, Donna Chang and Jan Shultis break down the major regulatory shakeups coming out of Washington—from the removal of CAR-T safety barriers to RFK Jr.’s sweeping promises to “clear the path” for innovation. With high-profile figures like Dr. Vinay Prasad and Dr. Carl June calling for less FDA oversight and faster approvals, it seems the tide is turning for cell and gene therapy pioneers.🔍 Topics We Cover:• Highlights from the June 5 CBER Roundtable• RFK Jr.'s new health leadership team and policy vision• Why Carl June wants early-stage CGT trials to skip FDA• Real-world impacts of the REMS removal for CAR-T• Why U.S. trials involving foreign labs are being halted• The rise of AI in drug approvals—helpful or dangerous?• The role of the new FDA Office of Therapeutic Products (OTP)• What it all means for autologous stem cell therapy💡 If you’re in the biotech, clinical research, or regenerative medicine space, this is essential listening. The rules are shifting—and your ability to deliver breakthrough therapies may finally get the green light.👇 Drop your thoughts in the comments:Is less regulation good for innovation? Or are we heading into risky territory?🔔 Subscribe for more episodes of the Stem Cell Revolution.📍 Produced by Hope BiosciencesLinks:WEBSITE - https://www.hope.bioINSTAGRAM -   / hope.bio  TWITTER -   / hopebiosciences  FACEBOOK -   / hopebiosciences  #StemCellRevolution #RegenerativeMedicine #RFKjr #CAR_T #FDAupdates #CellTherapy #GeneTherapy #Autologous #CBER #HopeBiosciences

As we close our CTTACC podcast series, we’re honored to be joined by a leader whose legacy spans medicine, military service, and national impact.Retired Major General Dr. Lester Martínez-López most recently served as the Assistant Secretary of Defense for Health Affairs @DeptofDefense, overseeing the health and medical readiness of over 9 million service members and their families. Prior to that, he led the @usarmy Medical Research and Materiel Command, helping to guide innovations in trauma care, biodefense, and military medicine for decades.In this grand finale episode, we reflect on:- How military medicine drives innovation in trauma and regenerative care- The future of health security and medical preparedness- The importance of regenerative medicine in military medicine- Leadership lessons from the battlefield to the federal benchDr. Martínez-López brings wisdom, experience, and a powerful perspective on how healing the wounded—whether in uniform or not—starts with bold vision and strategic investment.An inspiring and fitting close to a series dedicated to those advancing the future of healing.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / https://www.instagram.com/hope.bio/?h...X - / https://x.com/hopebiosciencesFACEBOOK - / facebook_1x.png / hopebiosciences #CTTACC2025 #LesterMartinezLopez #MilitaryMedicine #RegenerativeMedicine #TraumaCare #StemCells #DepartmentOfDefense #HealthInnovation #CombatMedicine #FutureOfHealing

What does it really take to bring a breakthrough therapy to patients with traumatic brain injury?In this powerful episode, we sit down with Dr. Charles Cox, a pioneer in trauma and regenerative medicine, for a wide-ranging conversation that spans decades of research, clinical insight, and unflinching honesty.Based in Houston, Dr. Cox is a Professor of Pediatric Surgery and Neurosurgery at  @UTHealthHouston  and a leading voice in stem cell therapy for TBI. He’s led some of the world’s most ambitious clinical trials aimed at healing the injured brain - and he’s faced every challenge the system can throw at a scientist.We cover:- The reality of treating traumatic brain injury- Why stem cells show promise—and what’s holding them back- Navigating the FDA and regulatory complexities- The emotional and scientific weight of trauma medicineThis is more than a science conversation. It’s a masterclass in resilience, purpose, and the fight to turn discovery into impact.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / https://www.instagram.com/hope.bio/?hl=enX - / https://x.com/hopebiosciencesFACEBOOK - / https://www.facebook.com/hopebiosciences/#tbi #traumaticbraininjury #stemcells #regenerativemedicine #CTTACC #uthealth #biotechnology #hopebio

We see them everywhere! Exosomes and extracellular vesicles, promoted in wellness products, skincare, and regenerative therapies. But even in medical communities, they're still widely misunderstood. That’s why we turned to one of the world’s leading experts to break it all down.In this episode of Stem Cell Revolution, we sit down with Dr. Aijun Wang, Chancellor’s Fellow and Professor of Surgery and Biomedical Engineering at UC Davis. Dr. Wang is a pioneering scientist, engineer, and entrepreneur whose work spans molecular biology, biomaterials, and clinical translation. He’s leading efforts to bring exosome-based therapeutics out of the lab and into real-world medicine.With over 180 peer-reviewed publications, 20+ patents, and multiple high-impact grants, Dr. Wang is setting the standard for how we understand and harness extracellular vesicles for healing.We dive into:- What exosomes and extracellular vesicles really are- How they’re being developed for clinical use- The engineering challenges behind therapeutic delivery- What’s next in nanomedicine and regenerative techWhether you're a clinician, researcher, or just curious about the science behind the buzzwords—this is the clarity you’ve been waiting for.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences#AijunWang #Exosomes #ExtracellularVesicles #Nanomedicine #RegenerativeMedicine #StemCellRevolution #UCDavis #CTTACC2025 #BiotechInnovation #CellTherapy #stemcell

He’s not predicting the future of medicine—he’s building it.In this electrifying episode, we sit down with Dr. Anthony Atala, a global icon in regenerative medicine and the visionary behind the Wake Forest Institute for Regenerative Medicine. A surgeon, scientist, and bioengineering pioneer, Dr. Atala has spent decades doing what most of us only dream about: growing human organs, engineering tissues, and bringing science fiction to life.With over 800 publications, 250 patents, and recognition from TIME Magazine for multiple “Top Medical Discoveries,” Dr. Atala is leading the charge into a new era of healthcare - one built cell by cell, layer by layer.We dive into:- 3D bioprinting of human tissues and organs- What it takes to move lab-grown structures into clinical use- The state of regenerative medicine today—and where it's going next- How innovation, collaboration, and purpose are driving real-world breakthroughsWhether you're in biotech, healthcare, or just captivated by what’s possible, this is one conversation you won’t want to miss.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences#AnthonyAtala #RegenerativeMedicine #OrganRegeneration #3DBioprinting #stemcell #StemCellRevolution #WakeForest #FutureOfMedicine #TissueEngineering #MedicalInnovation #CTTACC2025

This Memorial Day, we honor those who have given everything for our country—and welcome a guest whose life and work are a testament to service, sacrifice, and innovation in medicine.Dr. Michael Policastro is board-certified in emergency medicine and medical toxicology, and serves as Vice President of Business Development for a cutting-edge concierge medical practice. But when duty calls, he dons a uniform.As Colonel and Commander of the 445th Aeromedical Staging Squadron at Wright-Patterson Air Force Base, Dr. Policastro leads critical care air transport operations and oversees medical support for injured service members around the world. His deployments span Qatar during Operation Freedom’s Sentinel and Djibouti during Operation Enduring Freedom, earning him the Air Force Meritorious Service Medal and the title of Field Grade Officer of the Year.This is more than a conversation—it’s a powerful reminder of the courage, discipline, and heart behind the medicine that saves lives in the most extreme conditions.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences#MemorialDay #CombatMedicine #MilitaryInnovation #MichaelPolicastro #EmergencyMedicine #AirForceMedicine #RegenerativeMedicine #StemCellRevolution #VeteransCare #CriticalCareTransport #WrightPattersonAFB

Can stem cells regenerate the human heart?There’s no one better to answer that question than Dr. Chuck Murry, one of the world’s leading physician-scientists in iPS research.In this episode, we sit down with Dr. Murry, the newly appointed Chair of the Department of Stem Cell Biology and Regenerative Medicine and Director of the Broad Center for Regenerative Medicine and Stem Cell Research at the Keck School of Medicine of USC. With decades of NIH-funded research, more than 200 scientific publications, and leadership roles spanning academia and biotech, Dr. Murry has dedicated his career to translating breakthrough science into real treatments—accessible to the patients who need them most.We explore:How stem cells can help repair damaged heart tissueWhat it takes to move therapies from lab to clinicWhy accessibility and scalability are key to lasting impactThe future of regenerative cardiology and translational medicineWhether you’re in clinical care, biotech, or just fascinated by the promise of stem cells, this conversation offers deep insight from one of the field’s most accomplished voices.🎧 Watch now to learn how science is changing the future of heart disease.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences#ChuckMurry #StemCells #HeartRegeneration #USCStemCell #TranslationalMedicine #CardiologyInnovation #RegenerativeMedicine #StemCellRevolution #BiomedicalInnovation

In this episode, we sit down with Dr. Anthony Luke, a nationally recognized expert in sports medicine, orthopedics, and regenerative therapies, to dive into the facts—and fiction—surrounding Platelet-Rich Plasma (PRP).Dr. Luke is a Professor in the Department of Orthopaedic Surgery and Director of the UCSF Human Performance Center. With decades of experience caring for Olympians, professional athletes, and everyday patients, he brings a clear, evidence-based perspective to one of the most popular (and misunderstood) treatments in regenerative medicine.We cover:What PRP actually isWhen it works—and when it doesn’tHow it compares to stem cells and other therapiesThe future of PRP in sports and musculoskeletal careWhether you're a provider, patient, or just curious about cutting-edge treatments, this conversation is packed with clinical insight and straight talk from a true expert.🎧 Watch now and get the clarity you’ve been looking for.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences

In this episode, we kick off our CTTACC 2025 podcast series with none other than Dr. Shibani Pati, a visionary leader in trauma and regenerative medicine and the driving force behind one of the field’s most impactful gatherings.Dr. Pati is Vice Chair and Professor of the Department of Laboratory Medicine, and Director of the Center for Translational Research in Transfusion Medicine and Cellular Therapies at UCSF. As a nationally recognized expert in vascular repair and trauma resuscitation, she has made CTTACC into a must-attend event for anyone working at the intersection of science, innovation, and patient impact.In just 8 minutes, you’ll hear how her vision brought together the brightest minds in the field—and why this conference is setting the tone for the future of cellular and regenerative medicine.🎧 Short, powerful, and the perfect place to start our CTTACC series.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences#StemCellRevolution #RegenerativeMedicine #FDA #StemCells #HCTP #Biologics #SystemicEffect #ScienceWithMagic

In this episode of Stem Cell Revolution, hosts Donna Chang and Jan Shultis take listeners on a journey into the final—and perhaps most complex—criteria of the FDA’s HCT/P framework: systemic effect and the metabolic activity of living cells. Inspired by a recent trip to Disney World, Donna returns with fresh perspective (and a little pixie dust) to explore how the magic of stem cell science often runs into the reality of regulation.While the idea of cells working throughout the body to repair and restore sounds like science fiction come true, the FDA sees it differently. When stem cell therapies have systemic effects or rely on living cells to function, they cross the line into biologic drug territory—bringing with them a world of regulatory hurdles.Through compelling case studies and deep scientific discussion, Donna and Jan break down what counts as a systemic effect, how metabolic activity is interpreted by the FDA, and why some therapies are exempt—like autologous use and reproductive applications. They also explore the gray areas of cytokine secretion, paracrine signaling, and what truly defines a “local” effect.From clinics that crossed the line and got flagged to industry calls for reform, this episode sheds light on where the field stands—and where it’s headed. Whether you’re a researcher, policymaker, or patient advocate, this episode offers a thoughtful, imaginative look at how we balance innovation with oversight in regenerative medicine.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences#StemCellRevolution #RegenerativeMedicine #FDA #StemCells #HCTP #Biologics #SystemicEffect #ScienceWithMagic

In this episode of Stem Cell Revolution, hosts Donna Chang and Jan Shultis tackle one of the most misunderstood—but critical—FDA rules governing regenerative medicine: the “No Combination” clause. What happens when you mix stem cells with something else? A scaffold, a growth factor, or even a drug may seem like a harmless addition—but that single tweak could change everything.Donna and Jan unpack the FDA’s criteria for HCT/Ps under 21 CFR 1271, focusing on the third rule: no combination with other articles unless specifically allowed. With real-world examples and regulatory case studies, they explore how even well-intentioned innovations can push a treatment out of the HCT/P category and straight into drug regulation territory.From protecting patient safety to preserving innovation, this episode explores the fine line between regulation and overreach—and what it means for the future of cell-based medicine.Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - / hope.bioTWITTER - / hopebiosciencesFACEBOOK - / hopebiosciences#StemCellRevolution #RegenerativeMedicine #StemCellTherapy #FDARegulations

We’re hitting pause on stem cell regulations to bring you a special report on Donna Chang’s latest trip to HHS! Who did she meet? What was discussed? And what happens when Hope arrives in our nation’s capital? Watch now to find out!

Join us as we decode the FDA's playbook on homologous use! In this episode, we dive into the critical differences between HCT/Ps and drugs, unravel real-world examples, and explore the regulatory drama that shapes regenerative medicine. Tune in to discover how a simple definition can redefine the future of cellular therapies!Join the Conversation:Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences.Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Check out our website in the description below for more information or to order your exclusive "Not Plastic Bag" t-shirt!Links:HOPE STORE: https://www.hope.bio/merchWEBSITE - https://www.hope.bioINSTAGRAM - https://www.instagram.com/hope.bio/TWITTER - https://twitter.com/hopebiosciencesFACEBOOK - https://www.facebook.com/hopebiosciences#HopeBiosciences #StemCellResearch #YearInPhotos #Inspiration#StemCellRevolution #FDA #Regulation #MinimalManipulation #StemCellTherapy #2025

Join us for an insightful dive into the complex world of stem cell regulation in this episode of "Stem Cell Revolution." Recorded in early 2025, we explore the pivotal topic of minimal manipulation - a cornerstone in determining whether stem cell products are classified as drugs or human cell, tissue, or cellular and tissue-based products (HCT/Ps). Key Highlights: 00:00 - Intro and New Year Reflections 04:23 - Why Stem Cells are Regulated as Drugs 17:20 - Case Law on Minimal Manipulation 27:23 - The Future of Stem Cell Regulation Stem Cells. Bank Them. Fleece Sweatshirt: https://www.hope.bio/product-page/stem-cells-bank-them-cropped-fleece-pullover Join the Conversation: Your feedback is crucial! Ask us anything in the comments about stem cell therapies and their regulation, or share your experiences. Don't forget to like, subscribe, and hit the bell icon for more updates on stem cell research and its revolutionary potential in healthcare. Check out our website in the description below for more information or to order your exclusive "Not Plastic Bag" t-shirt! #StemCellRevolution #FDA #Regulation #MinimalManipulation #StemCellTherapy #2025

Join Donna Chang and Sherry Diers for a heartfelt and entertaining journey through Donna’s year in photos! In this episode, Donna opens up her camera roll to share the most meaningful, funny, and impactful moments of the past year. From behind-the-scenes highlights at Hope Biosciences to unforgettable milestones in groundbreaking stem cell research, this episode is packed with stories that celebrate progress, resilience, and hope. You’ll get an insider look at what it’s like to drive innovation in healthcare, from patient success stories to the incredible teamwork that makes it all possible. But it’s not all work—Donna shares personal moments that bring out the laughter and humanity behind the science. From candid snapshots to spontaneous memories, each photo tells a story of connection, determination, and the power of staying hopeful. Whether you’re passionate about medical advancements, inspired by personal growth, or just here for the feel-good vibes, this episode is sure to brighten your day. 👉 Don’t forget to LIKE, COMMENT, and SUBSCRIBE for more inspiring content from Hope Biosciences! Links: WEBSITE - https://www.hope.bio INSTAGRAM - https://www.instagram.com/hope.bio/ TWITTER - https://twitter.com/hopebiosciences FACEBOOK - https://www.facebook.com/hopebiosciences #HopeBiosciences #StemCellResearch #YearInPhotos #Inspiration

In this episode of Stem Cell Revolution, hosts Donna Chang and Jan Shultis return after a brief hiatus with a powerful recap of recent events and achievements in the stem cell field. They discuss Hope Biosciences’ landmark gala event, where they successfully raised over $1 million to advance their foundation’s mission, touching on the importance of community support and the next generation’s role in this movement. The conversation then shifts to the recent clinical trial successes, including a groundbreaking multiple sclerosis study. With the legal landscape for stem cell therapy evolving, Donna and Jan dive into a topic frequently asked about by their listeners: the legality of stem cells in research and treatment. The discussion sheds light on the early history of stem cell regulations, from embryonic research restrictions to the development of guidelines governing adult stem cell research. They cover the distinct regulatory pathways for different types of stem cell products, touching on significant milestones like the National Research Act, the Dickey-Wicker Amendment, and FDA’s evolving oversight role. Stay tuned for a deeper look at these complexities, as Donna and Jan aim to clarify the ongoing regulatory journey that shapes stem cell research and therapy today. Links: WEBSITE - https://www.hope.bio INSTAGRAM - https://www.instagram.com/hope.bio/ TWITTER - https://twitter.com/hopebiosciences FACEBOOK - https://www.facebook.com/hopebiosciences

In this episode of Stem Cell Revolution, host Donna Chang engages in a fascinating discussion with Sherry Diers about the groundbreaking world of mesenchymal stem cells (MSCs). The conversation delves into the fundamental differences between MSCs and hematopoietic stem cells, explaining that while hematopoietic stem cells need to be matched to prevent rejection, MSCs are remarkably adaptable and can be sourced from any donor without the same risk of immune rejection. Sherry and Donna explore how MSCs have shown significant promise in animal trials and numerous clinical studies, citing over 1200 trials with a large number achieving positive results. Despite this, MSCs are still awaiting broader approval in the U.S., leading to a deeper investigation into why many pivotal phase three trials have failed. They discuss the inherent challenges in scaling trials, variability in patient responses, and the difficulties in maintaining cell consistency across large trials. The conversation also touches on the challenges associated with autologous MSCs, including donor-to-donor variability and the complexities of scaling up production. Sherry and Donna examine the issues surrounding allogeneic MSCs, such as the need for consistent donor cell quality and the difficulties in mass production and preservation. The episode highlights the impressive safety record of MSCs and their potential in treating various conditions, including immune system disorders and cancer. Donna emphasizes that while MSCs have shown tremendous potential, the focus now is on resolving the technical challenges to fully harness their therapeutic capabilities. The discussion concludes with a hopeful outlook on the future of MSCs, emphasizing their role in treating, preventing, and potentially revolutionizing healthcare. Tune in to Stem Cell Revolution for an insightful exploration of the cutting-edge field of stem cell therapy and the promising future of MSCs. Links: WEBSITE - https://www.hope.bio INSTAGRAM -https://www.instagram.com/hope.bio/ TWITTER - https://twitter.com/hopebiosciences FACEBOOK -https://www.facebook.com/hopebiosciences

Welcome to another episode of the Stem Cell Revolution podcast, hosted by Donna Chang, Founder and CEO of Hope Biosciences. In this enlightening episode, Donna sits down with Jan Shultis to delve into the transformative world of stem cell therapy and the unique journey of Hope Biosciences. In This Episode: 1. The Origin Story of Hope Biosciences Donna and Jan discuss the unconventional beginnings of Hope Biosciences. Donna shares how the company was built not with traditional business models in mind but with a vision rooted in innovation, faith, and a commitment to people-centered care. They explore the unexpected paths and challenges faced in developing their groundbreaking technology. 2. The Personal Touch Behind the Technology The conversation highlights the deeply personal motivations driving Hope Biosciences' mission. Donna and Jan reflect on their roles as mothers and their aspirations for their children’s future health, emphasizing the importance of creating a legacy of advanced, accessible medical treatments. 3. Innovations in Stem Cell Therapy Donna and Jan break down the science behind Hope Biosciences' approach to stem cell therapy. They discuss their core technology, which focuses on using mesenchymal stem cells (MSCs) sourced from fat tissue to produce large quantities of high-quality cells. This approach aims to revolutionize treatment for chronic diseases and potentially pave the way for future medical advancements. 4. The Future of Stem Cell Technology The episode touches on the exciting possibilities of stem cell research, including the potential for regenerative medicine to address a wide range of health issues. Donna and Jan envision a future where preventive cell therapy becomes a cornerstone of healthcare, reducing the burden of chronic diseases and improving overall quality of life. 5. The Personal and Professional Impact Donna and Jan discuss the intersection of their professional passion with their personal lives. They reflect on the dedication required to drive forward this pioneering technology and the rewarding impact of making a difference in patients’ lives. 6. What's Next for Hope Biosciences The conversation wraps up with a look at future developments, including upcoming clinical trials and the continued commitment to advancing stem cell technology. Donna and Jan invite listeners to stay engaged with their journey and follow their updates. Stay Connected: Subscribe to the Stem Cell Revolution podcast for more inspiring stories and updates on stem cell research. Check out the Hope Biosciences Foundation's monthly updates for the latest in clinical trials and patient stories. Join Donna and Jan as they explore the revolutionary field of stem cell therapy and its potential to reshape the future of healthcare. Links: WEBSITE - https://www.hope.bio INSTAGRAM - https://www.instagram.com/hope.bio/ TWITTER - https://twitter.com/hopebiosciences FACEBOOK - https://www.facebook.com/hopebiosciences

Description